Natrilix (Indapamide Hemihydrate)

Indapamide is a thiazide‑like diuretic used in the management of cardiovascular conditions that involve fluid overload or elevated blood pressure.

• Hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular complications.
• Edema associated with congestive heart failure: promotes diuresis to decrease fluid accumulation and improve symptoms.
• Edema associated with renal disease: enhances urinary sodium and water excretion to alleviate swelling.

• Indapamide acts on the distal convoluted tubule of the nephron by inhibiting the Na⁺/Cl⁻ cotransporter. This blockade reduces sodium and chloride reabsorption, leading to increased urinary excretion of water and electrolytes. The resulting decrease in extracellular fluid volume lowers cardiac preload and systemic vascular resistance, thereby contributing to blood‑pressure reduction. Additionally, indapamide possesses mild vasodilatory properties mediated by calcium‑channel inhibition, which further assists in lowering peripheral resistance.

Indapamide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Increased urination: more frequent need to void, particularly during the first weeks of therapy.
• Electrolyte imbalance: mild changes in potassium or sodium levels that may cause muscle cramps.
• Dry mouth: reduced salivation leading to throat discomfort.

Serious or Rare Side Effects

• Severe dehydration: excessive fluid loss that can lead to hypotension and renal impairment.
• Hyperuricemia or gout flare: elevated uric acid levels precipitating joint pain.
• Allergic reactions: rash, itching, swelling, or anaphylaxis requiring immediate medical attention.

When prescribing indapamide, clinicians should consider several safety measures to minimize risks.

• Monitor electrolytes: check serum potassium, sodium and magnesium regularly during treatment.
• Assess renal function: evaluate creatinine clearance before initiation and periodically thereafter.
• Use caution in gout: the drug can raise uric acid levels, potentially triggering attacks.
• Avoid in severe hepatic impairment: impaired metabolism may increase drug exposure.
• Store at room temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Lithium: concurrent use may increase lithium concentrations and risk of toxicity.
• NSAIDs: may reduce the diuretic effect and increase risk of renal dysfunction.
• Digoxin: enhanced renal clearance can lower digoxin levels, requiring dose adjustment.

Moderate Interactions (Monitor Closely)

• Antidiabetic agents: diuretic‑induced hypokalemia can potentiate hypoglycemia.
• ACE inhibitors or ARBs: combined use may cause additive blood‑pressure lowering and electrolyte disturbances.
• Corticosteroids: may increase sodium and water retention, counteracting diuretic action.